BioInformant is your global leader in stem cell industry data.

As a specialty research company, we use technology to track and identify profitable opportunities within the stem cell sector and provide this data to clients pursuing aggressive growth.

Our leadership team comes from a bioinformatics background – the science of collecting and analyzing complex biological data such as genetic codes. As a result, we're trained in applying these novel data analysis techniques to the field of market research. Analyzing stem cell industry data is a breeze, compared to managing billions of DNA base pairs.

Put simply, we used advanced research techniques to stay ahead of our competition, so you can stay ahead of yours.

In addition, we are the only market intelligence company that has specifically served the stem cell market since it emerged.

Our singular focus on this industry and our historical knowledge of it makes us uniquely positioned to be your source of targeted, strategic information.

We began tracking the stem cell industry in 2004 when only two types of stem cells were commonly discussed, adult stem cells and embryonic stem cells. Today, researchers debate the number of stem cells in existence, as the number depends on whether stem cells are characterized functionally (e.g. neural stem cells, mesenchymal stem cells, induced pluripotent stem cells) or characterized by source tissue (e.g cord blood stem cells, dental pulp stem cells, amniotic stem cells, etc.).

What is clear is that dozens of stem cell types now exist, all representing unique opportunities for your company.

This means we understand the current and future product trends more intimately than any other company. When we say we’re a global leader in stem cell industry data, it is because it is our sole focus.

Due to our exclusive focus on stem cell markets, we have served nearly all of the world's leading research supply companies, including:

Leading Biotechnology Organizations We Have Served

GE Biosciences
Beckman Coulter
Life Technologies
BD Biosciences
Thermo Fischer Scientific
Corning, Inc.
Sigma Aldrich
Teva Pharmaceuticals
WARF (Wisconsin Alumni Research Foundation)
Novus Biologicals
Applied Stem Cell
Abcam Plc
MetaCyte Business Lab
University of Western Ontario
California Institute of Regenerative Medicine (CIRM)
Chugai Pharmaceutical Co., Ltd.
Kaneka Corporation
DS Pharma Biomedical Co., Ltd.
New York Stem Cell Foundation (NYSCF)
Stemcell Medicine Ltd
Cell Line Genetics, Inc.
North American Research and Innovation Center
Mediware Information Systems, Inc
HealthPoint Biotherapeutics
Axol Bioscience Ltd.
Angiocrine Biosciences
ViGene Biosciences, Inc.
Optimat Limited
Tissue Culture Biologics
Progenitor Life Sciences
Boston Consulting Group
BioLife Solutions
And Many More...

In addition, cord blood is richly populated with stem cells.

There are hematopoietic stem cells in cord blood and mesenchymal stem cells in cord tissue. There are also progenitor cells in both placental tissue and amniotic tissues. As such, we have also have been tracking the cord blood banking industry since 2006 and are also the leading supplier of cord blood industry data worldwide.

To date, we have also served nearly all of the world's leading cord blood banks, including:

Leading Cord Blood Banks We Have Served

Cells For Life Cord Blood Institute
Canadian Blood Services
CellCare Australia
Raynish Group
Cryo-Save AG
Neostem, Inc.
StemCyte, Inc.
Cord Life - Singapore
Virgin Health Bank
Insception Cord Blood Bank
California Institute of Regenerative Medicine (CIRM)
NHS Blood and Transplant (NHSBT)
New York Blood Center
Biosafe SA
Kaneka Corporation
Xytex Corporation
National Marrow Donor Program (NMDP)
The New Hope Center for Reproductive Medicine
SmartBank Italy
Till Group
Precious Cells
Health Advances (Strategy Consultants for the HealthCare Industry)
BioCells Argentina
And Many More...

Your trusted provider of stem cell industry data.

BioInformant has been featured on prominent news outlets that include the Wall Street Journal, Yahoo Finance, and CBS News. Our research has also been cited by sources that include Nature Biotechnology, Medical Ethics, MarketWatch, the National Marrow Donor Program, the Center for BioNetworking, and more. We've even been featured as a "Publisher Spotlight" on

However, we think that our clients say it best:

"I was truly impressed by BioInformant. You can trust BioInformant to do things right and generate greater awareness of your technology. They are the go-to resource for stem cell researchers and companies looking for trustworthy stem cell business information and marketing support."

Dr. William Frey II
Founder and Co-Director of the Alzheimer's Research Center

"I am now truly enlightened. You are awesome! I must say it has been an absolute pleasure working with you folks. You will always get a great customer recommendation from me."

John Jaskowiak
Vice President, Angiocrine Bioscience

A U.S. based company with headquarters in Roseville, MN, and Washington, DC.

As a U.S. based company, we are available to meet and speak with our clients. This allows us to understand your core objectives, which are to:

  1. Reduce overwhelm and make smarter decisions, faster
  2. Compete without the expense of new hires or a huge business development department
  3. Assess profitable opportunities within stem cell markets
  4. Develop high-demand products that will bring customers to you, instead of your competition
  5. Increase revenues and profitability within your organization
  6. Minimize risk by understanding competitive threats

In addition, every BioInformant client is given a complimentary follow-up call where we personally ask about your experience and utilization of the industry data that you have claimed. We track the stem cell industry continuously in real-time, so we have a unique ability to mastermind about your market strengths, weaknesses, opportunities, and threats. Currently, we are the only provider of stem cell market intelligence in the marketplace this offers this level of support. Again, our clients say it best:

"A special effort was made to render this excellent report accessible to us. The discussions that followed were very helpful and will contribute to the realization of our objective..."

Michael S. Pepper, MBChB, PhD, MD
Director, Institute for Cellular and Molecular Medicine
Professor, Dept. Immunology, Faculty of Health Sciences

The only provider of stem cell market intelligence that offers a guarantee.

Finally, BioInformant is the only provider of stem cell market intelligence in the marketplace that offers a 60-Day Money Back Guarantee to ensure your complete satisfaction. This means that you can claim stem cell market dominance, risk-free.

We look forward to becoming your trusted provider of stem cell industry data. Get started today by calling 703.859.7617, emailing, or using the Live Chat below.

We look forward to welcoming you to the BioInformant Team!

(Phone) 703-859-7617 (Fax) 614-352-2369

Copyright © 2014 BioInformant Worldwide, L.L.C. All rights reserved.

Home | Products | Guarantee | Company | Testimonials | Contact Us

60-Day Money Back Guarantee:
All BioInformant products come with a 100% Money Back Guarantee. If the strategies and tools aren't helpful to you - we'll cheerfully refund your money, and you can keep the product.

Follow Our Stem Cell Industry
Alerts on Twitter: